Gal-1 (Galectin-1) Upregulation Contributes to Abdominal Aortic Aneurysm Progression by Enhancing Vascular Inflammation

Supplemental Digital Content is available in the text. Objective: Abdominal aortic aneurysm (AAA) is a vascular degenerative disease causing sudden rupture of aorta and significant mortality in elders. Nevertheless, no prognostic and therapeutic target is available for disease management. Gal-1 (galectin-1) is a β-galactoside–binding lectin constitutively expressed in vasculature with roles in maintaining vascular homeostasis. This study aims to investigate the potential involvement of Gal-1 in AAA progression. Approach and Results: Gal-1 was significantly elevated in circulation and aortic tissues of Ang II (angiotensin II)–infused apoE-deficient mice developing AAA. Gal-1 deficiency reduced incidence and severity of AAA with lower expression of aortic MMPs (matrix metalloproteases) and proinflammatory cytokines. TNFα (tumor necrosis factor alpha) induced Gal-1 expression in cultured vascular smooth muscle cells and adventitial fibroblasts. Gal-1 deletion enhanced TNFα-induced MMP9 expression in fibroblasts but not vascular smooth muscle cells. Cysteinyl-labeling assay demonstrated that aortic Gal-1 exhibited susceptibility to oxidation in vivo. Recombinant oxidized Gal-1 induced expression of MMP9 and inflammatory cytokines to various extents in macrophages, vascular smooth muscle cells, and fibroblasts through activation of MAP (mitogen-activated protein) kinase signaling. Clinically, serum MMP9 level was significantly higher in both patients with AAA and coronary artery disease than in control subjects, whereas serum Gal-1 level was elevated in patients with AAA but not coronary artery disease when compared with controls. Conclusions: Gal-1 is highly induced and contributes to AAA by enhancing matrix degradation activity and inflammatory responses in experimental model. The pathological link between Gal-1 and AAA is also observed in human patients. These findings support the potential of Gal-1 as a disease biomarker and therapeutic target of AAA.

[1]  P. Wei,et al.  Galectin-1 Restricts Vascular Smooth Muscle Cell Motility Via Modulating Adhesion Force and Focal Adhesion Dynamics , 2018, Scientific Reports.

[2]  M. Fijak,et al.  Galectin-1 enhances TNFα-induced inflammatory responses in Sertoli cells through activation of MAPK signalling , 2018, Scientific Reports.

[3]  G. Rabinovich,et al.  Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation , 2017, Journal of Immunology.

[4]  J. Raffort,et al.  Monocytes and macrophages in abdominal aortic aneurysm , 2017, Nature Reviews Cardiology.

[5]  Y. Hu,et al.  ERK5 kinase activity is dispensable for cellular immune response and proliferation , 2016, Proceedings of the National Academy of Sciences.

[6]  I. Peshkova,et al.  Atherosclerosis and aortic aneurysm – is inflammation a common denominator? , 2016, The FEBS journal.

[7]  K. Kent,et al.  Clinical practice. Abdominal aortic aneurysms. , 2014, The New England journal of medicine.

[8]  G. Rabinovich,et al.  Structural basis of redox-dependent modulation of galectin-1 dynamics and function. , 2014, Glycobiology.

[9]  P. Tsao,et al.  Pathogenesis of abdominal aortic aneurysms: microRNAs, proteases, genetic associations. , 2014, Annual review of medicine.

[10]  G. Rabinovich,et al.  Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. , 2013, The American journal of pathology.

[11]  D. Morrison,et al.  MAP kinase pathways. , 2012, Cold Spring Harbor perspectives in biology.

[12]  Qingbo Xu,et al.  Hyperhomocysteinemia Exaggerates Adventitial Inflammation and Angiotensin II−Induced Abdominal Aortic Aneurysm in Mice , 2012, Circulation research.

[13]  C. Bhamidipati,et al.  Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. , 2011, The Journal of thoracic and cardiovascular surgery.

[14]  H. Inoue,et al.  Activation of RAW264.7 macrophages by oxidized galectin-1. , 2010, Immunology letters.

[15]  J. Golledge,et al.  Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[16]  U. Piomelli,et al.  The Murine Angiotensin II-Induced Abdominal Aortic Aneurysm Model: Rupture Risk and Inflammatory Progression Patterns , 2010, Front. Pharm..

[17]  Gani Bajraktari,et al.  Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  D. Milewicz,et al.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. , 2009, The Journal of clinical investigation.

[19]  J. Mactaggart,et al.  Blocking TNF-α Attenuates Aneurysm Formation in a Murine Model1 , 2009, The Journal of Immunology.

[20]  J. Carstensen,et al.  Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population , 2008, PloS one.

[21]  Masaaki Ito,et al.  Big Mitogen-Activated Protein Kinase: A New Player in Vascular Remodeling , 2007, Hypertension Research.

[22]  J. Harral,et al.  Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[23]  R. Kiss,et al.  Galectin-1: a small protein with major functions. , 2006, Glycobiology.

[24]  Ruud P. M. Dings,et al.  Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy , 2006, Proceedings of the National Academy of Sciences.

[25]  R. Charnigo,et al.  Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. , 2006, Journal of vascular surgery.

[26]  J. Lindholt,et al.  Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[27]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Kyung-Chan Kim,et al.  MAP Kinase activation is required for the MMP-9 induction by TNF-stimulation , 2005, Archives of pharmacal research.

[29]  D. Kass,et al.  p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart , 2005, Circulation.

[30]  K. Sunagawa,et al.  Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T. Masuda,et al.  Expression and localization of tumour necrosis factor-α and its converting enzyme in human abdominal aortic aneurysm , 2004 .

[32]  N. Hikawa,et al.  Oxidized Galectin-1 Stimulates Macrophages to Promote Axonal Regeneration in Peripheral Nerves after Axotomy , 2004, The Journal of Neuroscience.

[33]  A. Daugherty,et al.  Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[34]  F. Cambien,et al.  Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease , 2003, Circulation.

[35]  Y. Kloog,et al.  Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.

[36]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[37]  Stefano Iacobelli,et al.  Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.

[38]  Y. Kloog,et al.  Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation , 2001, Oncogene.

[39]  A. Cho,et al.  Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  J. Hedges,et al.  Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. , 2000, American journal of respiratory cell and molecular biology.

[41]  H. Horie,et al.  Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. , 2000, European journal of biochemistry.

[42]  Q. Javed,et al.  Galectin 1 is involved in vascular smooth muscle cell proliferation. , 2000, Cardiovascular research.

[43]  G. Hunninghake,et al.  Both Erk and p38 kinases are necessary for cytokine gene transcription. , 1999, American journal of respiratory cell and molecular biology.

[44]  E. P. Moiseeva,et al.  Galectin 1 Modulates Attachment, Spreading and Migration of Cultured Vascular Smooth Muscle Cells via Interactions with Cellular Receptors and Components ofExtracellu lar Matrix , 1999, Journal of Vascular Research.

[45]  R. Carruthers,et al.  Subunit molecular mass assignment of 14,654 Da to the soluble beta-galactoside-binding lectin from bovine heart muscle and demonstration of intramolecular disulfide bonding associated with oxidative inactivation. , 1992, The Journal of biological chemistry.

[46]  S. Barondes,et al.  Soluble lectins: a new class of extracellular proteins. , 1984, Science.